Sarepta Therapeutics
SRPT
#5103
Rank
โ‚น176.18 B
Marketcap
โ‚น1,668
Share price
-1.03%
Change (1 day)
-19.17%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2026 (TTM): -โ‚น10.31 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น1.97 Billion. In 2025 the company made an earning of -โ‚น67.67 Billion a decrease over its 2024 earnings that were of โ‚น25.12 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น10.31 Billion-84.77%
2025 -โ‚น67.67 Billion-369.28%
2024 โ‚น25.12 B-150.14%
2023 -โ‚น50.12 Billion-24.62%
2022 -โ‚น66.49 Billion64.69%
2021 -โ‚น40.37 Billion-24.25%
2020 -โ‚น53.3 Billion-22.53%
2019 -โ‚น68.79 Billion96.87%
2018 -โ‚น34.95 Billion645.68%
2017 -โ‚น4.69 Billion-81.81%
2016 -โ‚น25.76 Billion21.47%
2015 -โ‚น21.21 Billion62.04%
2014 -โ‚น13.09 Billion21.26%
2013 -โ‚น10.8 Billion60.93%
2012 -โ‚น6.71 Billion93.69%
2011 -โ‚น3.47 Billion71.58%
2010 -โ‚น2.02 Billion35.06%
2009 -โ‚น1.5 Billion-11.62%
2008 -โ‚น1.7 Billion-47.02%
2007 -โ‚น3.2 Billion0.38%
2006 -โ‚น3.18 Billion88.3%
2005 -โ‚น1.69 Billion-30.06%
2004 -โ‚น2.42 Billion32.69%
2003 -โ‚น1.82 Billion-25.52%
2002 -โ‚น2.45 Billion64.52%
2001 -โ‚น1.49 Billion50.4%
2000 -โ‚น0.99 Billion26.44%
1999 -โ‚น0.79 Billion8%
1998 -โ‚น0.73 Billion102.7%
1997 -โ‚น0.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-โ‚น188.39 Billion 1,393.28%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น6.47 Billion-48.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น21.53 Billion 70.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น108.37 B-959.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น76.45 Billion 505.94%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น36.74 Billion 191.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น65.98 Billion 422.94%๐Ÿ‡บ๐Ÿ‡ธ USA